Infectious
mononucleosis (IM), primarily caused by the Epstein-Barr virus (EBV), manifests
as the classic triad of fever, pharyngitis, and cervical lymphadenopathy.
Severe cases may involve organ damage, most commonly affecting the liver.
Diagnosis relies on a combination of clinical presentation and laboratory
parameters, with commonly used indicators including EBV-specific antibodies,
EBV-DNA load, and the ratio of atypical lymphocytes. Treatment primarily
involves symptomatic supportive care, with a cautious approach to the routine
use of antiviral medications. In recent years, significant research in
traditional Chinese medicine has been conducted in China, showing promising
advancements. This article provides a comprehensive review of EBV-induced
infectious mononucleosis, offering insights for clinical diagnosis and
treatment.
References
[1]
Fugl, A. and Andersen, C.L. (2019) Epstein-Barr Virus and Its Association with Disease—A Review of Relevance to General Practice. BMC Family Practice, 20, Article No. 62. https://doi.org/10.1186/s12875-019-0954-3
[2]
Yuan, L.P., Wang, J.S. and Fan, X.C. (2021) Clinical Characteristics and Pidemiological Analysis of Infectious Mononucleosis in Children. Chinese Journal of Clinical Research, 34, 1031-1034. http://doi.org/10.13429/j.cnki.cjcr.2021.08.005
[3]
Gao, Y. (2020) Epidemiological Characteristics and Clinical Features Analysis of 73 Patients with Infectious Mononucleosis. Master’s Thesis, Kunming Medical University, Kunming. http://doi.org/10.27202/d.cnki.gkmyc.2020.000112
[4]
Liu, M., Wang, X., Zhang, L., et al. (2022) Epidemiological Characteristics and Disease Burden of Infectious Mononucleosis in Hospitalized Children in China: A Nationwide Retrospective Study. Virologica Sinica, 37, 637-645.
https://doi.org/10.1016/j.virs.2022.07.007
[5]
Kuri, A., Jacobs, B.M., Vickaryous, N., et al. (2020) Epidemiology of Epstein-Barr Virus Infection and Infectious Mononucleosis in the United Kingdom. BMC Public Health, 20, Article No. 912. https://doi.org/10.1186/s12889-020-09049-x
[6]
Bolis, V., Karadedos, C., Chiotis, I., et al. (2016) Atypical Manifestations of Epstein-Barr Virus in Children: A Diagnostic Challenge. Jornal de Pediatria, 92, 113-121. https://doi.org/10.1016/j.jped.2015.06.007
[7]
Fafi-Kremer, S., Morand, P., Brion, J.P., et al. (2005) Long-Term Shedding of Infectious Epstein-Barr Virus after Infectious Mononucleosis. The Journal of Infectious Diseases, 191, 985-989. https://doi.org/10.1086/428097
[8]
Grimm, J.M., Schmeling, D.O., Dunmire, S.K., et al. (2016) Prospective Studies of Infectious Mononucleosis in University Students. Clinical & Translational Immunology, 5, e94. https://doi.org/10.1038/cti.2016.48
[9]
Lang, D.J., Garruto, R.M. and Gajdusek, D.C. (1977) Early Acquisition of Cytomegalovirus and Epstein-Barr Virus Antibody in Several Isolated Melanesian Populations. American Journal of Epidemiology, 105, 480-487.
https://doi.org/10.1093/oxfordjournals.aje.a112407
[10]
Dunmire, S.K., Verghese, P.S. and Balfour Jr., H.H. (2018) Primary Epstein-Barr Virus Infection. Journal of Clinical Virology, 102, 84-92.
https://doi.org/10.1016/j.jcv.2018.03.001
[11]
Rostgaard, K., Stensballe, L.G., Søegaard, S.H., Kamper-Jørgensen, M. and Hjalgrim, H. (2021) Childcare Attendance and Risk of Infectious Mononucleosis: A Population-Based Danish Cohort Study. PLOS ONE, 16, e0261665.
https://doi.org/10.1371/journal.pone.0261665
[12]
Huang, W., Bai, L. and Tang, H. (2023) Epstein-Barr Virus Infection: The Micro and Macro Worlds. Virology Journal, 20, Article No. 220.
https://doi.org/10.1186/s12985-023-02187-9
[13]
Li, H., Liu, D. and Li, X. (2020) HLA-DPB1 and Epstein-Barr Virus gp42 Protein Jointly Contribute to the Development of Hodgkin Lymphoma. Translational Cancer Research, 9, 4424-4432. https://doi.org/10.21037/tcr-20-2070
[14]
Jangra, S., Yuen, K.S., Botelho, M.G., et al. (2019) Epstein-Barr Virus and Innate Immunity: Friends or Foes? Microorganisms, 7, Article 183.
https://doi.org/10.3390/microorganisms7060183
[15]
Liu, M., Wang, R. and Xie, Z. (2023) T Cell-Mediated Immunity during Epstein-Barr Virus Infections in Children. Infection, Genetics and Evolution, 112, Article ID: 105443. https://doi.org/10.1016/j.meegid.2023.105443
[16]
Zhang, L., Liu, M., Zhang, M., et al. (2022) Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis. Journal of Visualized Experiments, 187, 985-989. https://doi.org/10.3791/64212
[17]
Jiang, Y.Q., Cao, B.R. and Wang, F. (2023) The Clinical Value of Peripheral Blood Lymphocyte Sbsets and NK Cell Detection in the Diagnosis of Infectious Mononucleosis in Children. Journal of Qiqihar Medical University, 44, 242-245.
http://doi.org/10.3969/j.issn.1002-1256.2023.03.010
[18]
Rostgaard, K., Nielsen, T.R., Wohlfahrt, J., et al. (2014) Sibship Structure and Risk of Infectious Mononucleosis: A Population-Based Cohort Study. International Journal of Epidemiology, 43, 1607-1614. https://doi.org/10.1093/ije/dyu118
[19]
Hwang, A.E., Hamilton, A.S., Cockburn, M.G., et al. (2012) Evidence of Genetic Susceptibility to Infectious Mononucleosis: A Twin Study. Epidemiology and Infection, 140, 2089-2095. https://doi.org/10.1017/S0950268811002457
[20]
Huang, X.W., Wang, H., Xu, X., et al. (2023) Early Identification and Correlation Analysis of Infectious Mononucleosis and Acute Suppurative Tonsillitis in Children. Chinese Journal of General Practice, 21, 1698-1701, 1748.
http://doi.org/10.16766/j.cnki.issn.1674-4152.003204
[21]
Wu, Y.Y. (2022) Clinical Characteristics of 134 Children with Epstein-Barr Virus Associated Infectious Mononucleosis. Medical Innovation of China, 19, 173-176.
http://doi.org/10.3969/j.issn.1674-4985.2022.08.042
[22]
Patel, B.M. (1967) Skin Rash with Infectious Mononucleosis and Ampicillin. Pediatrics, 40, 910-911. https://doi.org/10.1542/peds.40.5.910
[23]
Kerns, D., Shira, J.E., Go, S., et al. (1973) Ampicillin Rash in Children. Relationship to Penicillin Allergy and Infectious Mononucleosis. The American Journal of Diseases of Children, 125, 187-190.
https://doi.org/10.1001/archpedi.1973.04160020023004
[24]
Zhang, J.X., Xie, J., Fan, L., et al. (2022) Evaluation of the Association between the Use of Antimicrobials and the Risk of Rash in Patients with Infectious Mononucleosis: Systematinc Review and Meta-Analysis. Chinese Journal of Hospital Pharmacy, 42, 281-287. http://doi.org/10.13286/j.1001-5213.2022.03.10
Song, Y.D. and Yang, W.X. (2022) Characteristics of Complications of Infectious Mononucleosis in Children. Chinese and Foreign Medical Research, 20, 118-121.
http://doi.org/10.14033/j.cnki.cfmr.2022.06.033
[27]
Sylvester, J.E., Buchanan, B.K., Paradise, S.L., et al. (2019) Association of Splenic Rupture and Infectious Mononucleosis: A Retrospective Analysis and Review of Return-to-Play Recommendations. Sports Health, 11, 543-549.
https://doi.org/10.1177/1941738119873665
[28]
Tan, E.T., Wilkinson, D. and Edafe, O. (2022) The Utility of Liver Function Tests and Abdominal Ultrasound in Infectious Mononucleosis—A Systematic Review. Clinical Otolaryngology, 47, 611-619. https://doi.org/10.1111/coa.13965
[29]
Yan, Y. and Yuan, Y.L. (2023) An Analysis of Clinical and Laboratory Characteristics of Children with Infectious Mononucleosis. Labeled Immunoassays and Clinical Medicine, 30, 1316-1320.
[30]
Njoku, K., Ramchander, N.C., Wan, Y.L., et al. (2022) Pre-Treatment Inflammatory Parameters Predict Survival from Endometrial Cancer: A Prospective Database Analysis. Gynecologic Oncology, 164, 146-153.
https://doi.org/10.1016/j.ygyno.2021.11.009
[31]
Luo, N.D., Huang, J.J., Sun, A.X., et al. (2023) Diagnostic Value and Correlation Analysis of NLR, MLR and RDW in Children with Infectious Mononucleosis. Journal of Medical Research, 52, 94-98.
[32]
Abusalah, M.A.H., Gan, S.H., Al-Hatamleh, M.A.I., et al. (2020) Recent Advances in Diagnostic Approaches for Epstein-Barr Virus. Pathogens, 9, Article 226.
https://doi.org/10.3390/pathogens9030226
[33]
Liu, H.J., Tong, X.X., Li, D., et al. (2023) Diagnostic Value of EBV Antibodies Combined with EBV-DNA Load in Pediatric Patients with Infectious Mononucleosis. Guizhou Medical Journal, 47, 1635-1636.
http://doi.org/10.3969/j.issn.1000-744X.2023.10.072
[34]
Guo, R. and Li, Q.Y. (2019) Advances in Diagnosis and Treatment of Infectious Mononucleosis in Children. China Clinical Practical Medicine, 2, 78-80.
http://doi.org/10.3760/cma.j.issn.1673-8799.2019.02.022
[35]
Shi, T., Li, J., Miao, Y., et al. (2022) Adenosine Deaminase as a Marker for the Severity of Infectious Mononucleosis Secondary to EBV in Children. BMC Infectious Diseases, 22, Article No. 164. https://doi.org/10.1186/s12879-022-07150-7
[36]
Subspecialty Group of Infectious Diseases, the Society of Pediatrics, Chinese Medical Association and National Children’s Epstein-Barr Virus Infection Cooperative Group (2021) Experts Consensus on Diagnosis and Treatment of Epstein-Barr Virus Infection-Related Diseases in Children. Chinese Journal of Pediatrics, 59, 905-911. http://doi.org/10.3760/cma.j.cn112140-20210618-00513
[37]
Cao, X.L., Chen, M.L., Hu, X.S., et al. (2023) Diagnostic Efficacy of VCA-IgM in Combination with EB-DNA for Diagnosis of Infectious Mononucleosis in Children. Chinese Journal of Nosocomiology, 33, 1741-1745.
[38]
Ge, J., Guan, Y., Cui, J., et al. (2021) Comparative Study of Different Antiviral Treatment Strategies for Children with Infectious Mononucleosis. Chinese Journal of Drug Application and Monitoring, 18, 294-296, 307.
http://doi.org/10.3969/j.issn.1672-8157.2021.05.003
[39]
De Paor, M., O’Brien, K., Fahey, T. and Smith, S.M. (2016) Antiviral Agents for Infectious Mononucleosis (Glandular Fever). Cochrane Database of Systematic Reviews, 12, CD011487. https://doi.org/10.1002/14651858.CD011487.pub2
[40]
Zhang, W. and Xu, G.C. (2022) Progress in Antiviral Treatment of Infectious Mononucleosis in Children. Journal of Qiqihar University of Medicine, 43, 688-692.
http://doi.org/10.3969/j.issn.1002-1256.2022.07.021
[41]
Hu, H., Deng, H., Bi, J., et al. (2021) Clinical Characteristics and Effectiveness of Antiviral Agents in Hospitalized Children with Infectious Mononucleosis in China: A Multicenter Retrospective Study. Pediatric Investigation, 5, 188-194.
https://doi.org/10.1002/ped4.12294
[42]
Wang, H.B., Fu, G.Y., Ren, W.J., et al. (2023) Meta-Analysis of Effectiveness and Safety of Interferon α in Treatment of Infectious Mononucleosis. Chinese Journal of Nosocomiology, 33, 203-208.
[43]
Gomes, K. and Goldman, R.D. (2023) Corticosteroids for Infectious Mononucleosis. Canadian Family Physician, 69, 101-102. https://doi.org/10.46747/cfp.6902101
[44]
Gatica, C., Soffia, P., Charles, R., et al. (2021) [Spontaneous Splenic Rupture Secondary to Infectious Mononucleosis]. Revista chilena de infectología, 38, 292-296.
https://doi.org/10.4067/S0716-10182021000200292
[45]
Song, M.J., Song, Z., Zhang, H., et al. (2020) Treatment Progress in Chinese and Western Medicine Treatment for Infectious Mononucleosis in Children. Chinese Pediatrics of Integrated Traditional and Western Medicine, 12, 492-496.
http://doi.org/10.3969/j.issn.1674-3865.2020.06.006
[46]
Xie, H.D., Yu, M.F., Long, T.W., et al. (2022) Clinical Effect of Qingyan Lige Decoction in the Treatment of Children with Infectious Mononucleosis. Chinese Pediatrics of Integrated Traditional and Western Medicine, 14, 72-75.
http://doi.org/10.3969/j.issn.16743865.2022.01.018
[47]
Xu, X.M., Gao, J. and Chen, B.Q. (20210 Clinical Effect of Reduning Combined with Vidarabine on Infectious Mononucleosis and Its Effect on T lymphocyte Subsets an Inflammatory Factor Levels. China Medicine, 16, 1874-1877.
[48]
Sun, X.X., Li, X.F. and Ma, S.X. (2021) Clinical Study on Treatment of Epstein-Barr Virus Related Infectious Mononucleosis in Children with Modified Wonderfully Effective Four Epidemic-Clearing Toxin-Resolving Beverage. Henan Traditional Chinese Medicine, 41, 1210-1213.
http://doi.org/10.16367/j.issn.1003-5028.2021.08.0275
[49]
Yan, Y.B., Sun, X.X. and Zhang, H.J. (2016) Clinical Study on Simiao Qingwenbaiduyin Treatment of Excessive Heat Toxin Children Infectious Mononucleosis. China Journal of Chinese Medicine, 31, 599-602.
http://doi.org/10.16368/j.issn.1674-8999.2016.04.169
[50]
Cui, X. and Snapper, C.M. (2021) Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases. Frontiers in Immunology, 12, Article ID: 734471. https://doi.org/10.3389/fimmu.2021.734471
